BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3546144)

  • 21. Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study.
    Stuart RK; Braine HG; Lietman PS; Saral R; Fuller DJ
    Am J Med; 1980 Jun; 68(6):876-85. PubMed ID: 6992570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.
    Nováková I; Donnelly P; De Pauw B
    Scand J Infect Dis; 1990; 22(6):705-11. PubMed ID: 2284577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies.
    Gualtieri RJ; Donowitz GR; Kaiser DL; Hess CE; Sande MA
    Am J Med; 1983 Jun; 74(6):934-40. PubMed ID: 6407305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
    Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients.
    Liu CY; Wang FD
    Chemotherapy; 1989; 35 Suppl 2():16-22. PubMed ID: 2692982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous sulfamethoxazole-trimethoprim plus ticarcillin as empiric antibiotic therapy for granulocytopenic patient.
    Schimpff S
    Arch Intern Med; 1981 Jun; 141(7):844-6. PubMed ID: 7235802
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
    Feliu J; Artal A; González Barón M; Berrocal A; Chacón I; García de Paredes ML; Espinosa E; Ordóñez A; Zamora P; Montero JM
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2816-20. PubMed ID: 1482151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients.
    Krcméry V; Koza I; Mardiak J; Fuchsberger P; Spánik S; Trupl J; Horníková M; Kusenda Z; Sufliarsky J; Svec J
    Chemotherapy; 1992; 38(1):74-6. PubMed ID: 1618007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
    Marty M; Gisselbrecht C; Samson-Lepors MJ
    Nouv Presse Med; 1979 Oct; 8(42):3465-8. PubMed ID: 537897
    [No Abstract]   [Full Text] [Related]  

  • 31. [Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia].
    Sampi K; Kumai R; Sakurai M; Kaneko Y; Hattori M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1301-5. PubMed ID: 4004291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients.
    Nováková IR; Donnelly JP; de Pauw BE
    Ann Hematol; 1991 Oct; 63(4):195-200. PubMed ID: 1932297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of infectious outbreaks in neutropenic patients with a piperacillin and amikacin combination].
    Calvo F; de Castro H; Brice P
    Presse Med; 1986 Dec; 15(46):2353-7. PubMed ID: 2949286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
    Klastersky J; Glauser MP; Schimpff SC; Zinner SH; Gaya H
    Antimicrob Agents Chemother; 1986 Feb; 29(2):263-70. PubMed ID: 3521475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mycetomas with pulmonary dissemination].
    Welsh Lozano O; López López JR
    Med Cutan Ibero Lat Am; 1985; 13(6):517-23. PubMed ID: 3914605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Rizal AM; Nordiah AJ; Jamal R
    Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
    Braine HG; Stuart RK; Saral R; Lietman PS
    Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carbenicillin-trimethoprim/sulphamethoxazole or carbenicillin-tobramycin as empirical treatment of infection in granulocytopenic patients. A controlled prospective trial (author's transl)].
    Rafecas FJ; Sanz MA; Balaguer H; Santos M; Besalduch J; Martinez J; Marty ML; Gobernado M
    Sangre (Barc); 1981; 26(3):335-46. PubMed ID: 7027489
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
    Del Favero A; Menichetti F; Guerciolini R; Bucaneve G; Baldelli F; Aversa F; Terenzi A; Davis S; Pauluzzi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1126-9. PubMed ID: 2959198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.